ClinicalTrials.Veeva

Menu
H

hVIVO Services Limited | Queen Mary BioEnterprises Innovation Centre

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Neumifil
CC-42344
JNJ-64281802
EDP-323
JNJ-64417184
Palivizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

Influenza Viral Challenge Study of CC-42344 in Healthy Participants

Participants in this study will be given either CC-42344 (one of two dose levels) or placebo orally for 5 days after receiving an influenza (flu) cha...

Enrolling
Influenza A
Drug: Placebo
Drug: CC-42344

Healthy adult participants will be challenged with the H1N1 Influenza virus and then treated with either SAB-176 or placebo.

Active, not recruiting
Influenza A H1N1
Other: Placebo
Biological: SAB-176

Trial sponsors

Bavarian Nordic logo
C
C
Enanta Pharmaceuticals logo
H
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
Janssen (J&J Innovative Medicine) logo
P
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems